Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

PARADIGM LABS, LLC

NPI: 1184041949 · BRUNSWICK, GA 31520 · Clinical Medical Laboratory · NPI assigned 03/18/2014

$19.64M
Total Medicaid Paid
236,064
Total Claims
146,806
Beneficiaries
17
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialWOLFE, CATHERINE (PRESIDENT/CEO)
NPI Enumeration Date03/18/2014

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 34,762 $3.86M
2019 39,399 $3.29M
2020 28,944 $2.98M
2021 30,520 $3.27M
2022 33,738 $2.52M
2023 31,929 $1.74M
2024 36,772 $1.98M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed 37,737 27,401 $6.58M
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed 33,522 25,050 $4.33M
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 80,848 46,069 $4.06M
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 64,309 32,153 $3.06M
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed 19,056 15,592 $1.61M
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 55 54 $1K
82607 51 51 $892.13
80061 Lipid panel 39 38 $519.45
83036 Hemoglobin; glycosylated (A1C) 55 54 $435.30
84443 Thyroid stimulating hormone (TSH) 44 44 $288.41
80053 Comprehensive metabolic panel 61 61 $285.39
84439 52 40 $240.56
85025 Blood count; complete (CBC), automated, and automated differential WBC count 46 46 $166.48
36415 Collection of venous blood by venipuncture 95 80 $119.97
80050 General health panel 44 23 $103.50
84479 25 25 $0.00
84436 25 25 $0.00